Manager
Janus Henderson Investors
Sector
Healthcare and Biotechnology
Structure
OEIC
Part of
Domicile
United Kingdom
Currency
GBP
Launched
14 Sept 2023
Benchmark
MSCI World Health Care Index
| Annualised (a year) |
| Since launch | +11.40% | +7.11% | +5.89% | — |
| AstraZeneca |
| 3.67% |
| 6 | Novartis | 2.80% |
| 7 | Thermo Fisher Scientific | 2.69% |
| 8 | Revolution Medicines | 2.68% |
| 9 | Argenx | 2.44% |
| 10 | Roche | 2.29% |
| Switzerland | 5.1% |
| United Kingdom | 3.7% |
| Belgium | 3.0% |
| France | 2.2% |
| Denmark | 1.6% |
| Israel | 1.2% |
| Japan | 0.3% |
| Over $500B | 16.6% | |
| $100B to $500B | 40.6% | |
| $50B to $100B | 7.5% | |
| $25B to $50B | 7.6% | |
| $10B to $25B | 8.5% | |
| $5B to $10B | 13.6% | |
| $1B to $5B | 4.0% | |
| $250M to $1B | 0.7% |
| — |